Filter News

Bone Metastasis Market Size 2022 to 2030 - Quantitative Research by QYResearch Medical

Published: Nov 15, 2022

The global bone metastasis market size was significantly robust in 2021 and is expected to register a rapid revenue CAGR over the forecast period. Bone metastasis market revenue growth is primarily driven by the rise in cancer incidences globally.

Bone metastasis is a type of cancerous growth that spreads from the original site to the bone. Nearly all types of cancer spread to the bones, specifically breast and prostate cancer spreads faster to the bones than any other type. Bone metastasis commonly occurs in the spine, pelvis, and thigh. Bone metastasis can be the first sign of cancer but may also occur after the cancer treatment. The various symptoms of bone metastasis include bone pain, broken bones, weakness, and high calcium levels in the blood causing nausea, vomiting, constipation, and confusion. Also, some of the symptoms like urinary and bowel incontinence are also seen.

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118334

Some of the factors supporting the market growth
Drivers:

Increasing prevalence of bone metastasis due to the rise in cancer cases in the growing population because of the rise in unhealthy lifestyle is one of the major factors driving revenue growth of the bone metastasis market.

Increase in the geriatric population with a higher chance of suffering from cancer and a rise in breast, prostate, lung, lymphoma, and thyroid cancer in the population increase the risk of bone metastasis and thus contributes to the market revenue growth of bone metastasis.

Technological advancements and the rise in research and drug development for the treatment of almost all types of cancer supports revenue growth of the bone metastasis market.

Restraints:

High cost of cancer treatment and slow drug approval by Food and Drug Administration (FDA) for the cancer treatment are major factors restraining the growth of the bone metastasis market. Also, less diagnostic techniques for bone metastasis hamper the market revenue growth of bone metastasis.

Opportunities:

Technological advancements in the surgical and non-surgical cancer treatment with novel techniques, improved healthcare facilities with the rise in the research and development for the treatment of bone metastasis, and government initiatives in spreading awareness about the symptoms and the available treatment for bone metastasis, also increase in healthcare investment day by day will witness lucrative growth opportunities in the forecast period.

Geographic Market Scenario
Largest Market Share:

Among regional markets for bone metastasis, North America emerged to be the largest with the highest revenue share. Revenue growth in North American region is attributed to the rising healthcare expenditure, increasing awareness, and rising incidence of bone metastasis in this region.

Related Reports:

Fastest Growing Market:

Asia Pacific bone metastasis market is expected to register the fastest revenue growth rate over the forecast period. Rising number of patients with bone metastasis, government initiatives to promote awareness, and rise in the demand for the treatment are some of the other factors responsible for the market growth in the region. Also, the presence of large population is one of the factors expected to positively impact the bone metastasis market growth during the forecast period.

Key market trends and innovation

  • Beijing Cancer Hospital Beijing, Beijing, China under the sponsorship of Qilu Pharmaceuticals Co., Ltd. doing phase 3 study on the efficacy and safety of QL1206 and Xgeva in patients with bone metastasis from solid tumors.
  • The First Affiliated Hospital of Guangdong Pharmaceutical University Guangzhou, China under the sponsorship of Luye Pharma Group Ltd. doing phase 3 study on the safety and efficacy of LY01011 and Xgeva in patients with bone metastasis from solid tumors.

Major Companies in the Market

  • AngioDynamics
  • Koninklijke Philips N.V.
  • Braun Meisungen AG
  • Cardinal Health
  • Radius Health, Inc.
  • Fresenius Kabi AG
  • Novartis AG
  • Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • Johnson & Johnson

What Our Report Provides and Why Our Offering Is Better

This report offers historical data points, forecast, and revenue growth at a global regional & country level, and provides analysis, industry trends, and consumption pattern details for each region, major country, and segment from 2019-2030. The global market report includes industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contribution by each regional and country market. In addition, the report offers industry analysis and competitive landscape, company financials, and impact analysis.         

Inquiry Before Buying@ https://qyresearchmedical.com/submit-inquiry/118334                                                

Type Outlook (Revenue, USD Billion; 2019-2030)

  • Osteolytic bone metastasis
  • Osteoblastic bone metastasis
  • Mixed bone metastasis

Origin Outlook (Revenue, USD Billion; 2019-2030)

  • Breast
  • Lung
  • Thyroid
  • Kidney
  • Prostate

Treatment Outlook (Revenue, USD Billion; 2019-2030)

  • Analgesics
  • Bone building drugs
  • Targeted therapy agents
  • Chemotherapeutic agents
  • Hormone supplements

Product Type Outlook (Revenue, USD Billion; 2019-2030)

  • Tablets
  • Injectable

Dosage Forms Outlook (Revenue, USD Billion; 2019-2030)

  • Solid
  • Liquid

Route of Administration (Revenue, USD Billion; 2019-2030)

  • Oral
  • Parenteral

Age Outlook (Revenue, USD Billion; 2019-2030)

  • Paediatrics
  • Adults
  • Geriatrics

Gender Outlook (Revenue, USD Billion; 2019-2030)

  • Female
  • Male

End-User Outlook (Revenue, USD Billion; 2019-2030)

  • Hospital pharmacy
  • Online pharmacy
  • Retail pharmacy

Prescription Type Outlook (Revenue, USD Billion; 2019-2030)

  • Over the counter (OTC) drugs
  • Prescription (Rx) drugs

Distribution Channel Outlook (Revenue, USD Billion; 2019-2030)

  • Offline
  • Online

Regional Outlook (Revenue, USD Billion; 2019-2030)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • BENELUX
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Buy quantitative research Report at discounted price - USD 1500 https://qyresearchmedical.com/report/checkout/118334/1500

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL - http://www.qyresearchmedical.com/

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

 

Back to news